Display options
Cite
Abdalla Abbas M, Guenther A, Galantucci S, et al. Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options. Open Neurol J. 2008;2:20-4doi: 10.2174/1874205X00802010020.
Abdalla Abbas, M., Guenther, A., Galantucci, S., Fawi, G., Comi, G., Kwan, J., & Corea, F. (2008). Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options. The open neurology journal, 220-4. https://doi.org/10.2174/1874205X00802010020
Abdalla Abbas, Mohammed, et al. "Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options." The open neurology journal vol. 2 (2008): 20-4. doi: https://doi.org/10.2174/1874205X00802010020
Abdalla Abbas M, Guenther A, Galantucci S, Fawi G, Comi G, Kwan J, Corea F. Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options. Open Neurol J. 2008;2:20-4. doi: 10.2174/1874205X00802010020. Epub 2008 May 07. PMID: 19018303; PMCID: PMC2577933.
Copy Download .nbib Format: NLM
Share it on

Open Neurol J. 2008;2:20-4. doi: 10.2174/1874205X00802010020. Epub 2008 May 07.

Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options.

The open neurology journal

Mohammed Abdalla Abbas, Albrecht Guenther, Sebastiano Galantucci, Gharib Fawi, Giancarlo Comi, Joseph Kwan, Francesco Corea

Affiliations

  1. Neurology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.

PMID: 19018303 PMCID: PMC2577933 DOI: 10.2174/1874205X00802010020

Abstract

Infection and inflammation may have a crucial role in the pathogenesis of atherosclerosis. This hypothesis is supported by an increasing number of reports on the interaction between chronic infection, inflammation, and atherogenesis. Assessment of serological and inflammatory markers of infection may be useful adjuncts in identifying those patients who are at a higher risk of developing vascular events, and in whom more aggressive treatments might be warranted.

Keywords: Chlamydia pneumoniae; Cytomegalovirus; Helicobacter pylori; Stroke; antibiotics; atherosclerosis; infection; odontopathogens; risk factors; therapy

References

  1. Clin Infect Dis. 1997 Dec;25(6):1495-6 - PubMed
  2. Rev Infect Dis. 1990 Sep-Oct;12 Suppl 7:S727-36 - PubMed
  3. J Periodontol. 2005 Nov;76(11 Suppl):2085-8 - PubMed
  4. APMIS. 1995 Nov;103(11):769-96 - PubMed
  5. Clin Microbiol Infect. 2002 Oct;8(10):654-61 - PubMed
  6. Stroke. 1996 Dec;27(12):2207-10 - PubMed
  7. Clin Infect Dis. 2003 Jun 1;36(11):E134-9 - PubMed
  8. J Vasc Surg. 1997 Mar;25(3):499-505 - PubMed
  9. Ann Med. 1991;23(5):539-43 - PubMed
  10. J Neurol Sci. 1981 Sep;51(3):395-410 - PubMed
  11. Atherosclerosis. 2005 Dec;183(2):342-8 - PubMed
  12. Arch Med Res. 2006 Jul;37(5):687-8 - PubMed
  13. Stroke. 1999 Feb;30(2):299-305 - PubMed
  14. Circulation. 2000 Aug 22;102(8):833-9 - PubMed
  15. J Infect Dis. 2003 Oct 15;188(8):1094-7 - PubMed
  16. Stroke. 1999 Jan;30(1):16-20 - PubMed
  17. Circulation. 2000 Oct 17;102(16):1917-23 - PubMed
  18. J Am Coll Cardiol. 1998 Jul;32(1):35-41 - PubMed
  19. J Infect Dis. 1998 Jan;177(1):209-12 - PubMed
  20. Heart. 1999 Mar;81(3):239-44 - PubMed
  21. Transplantation. 2003 Nov 27;76(10):1470-4 - PubMed
  22. Crit Rev Oral Biol Med. 2004 Nov 01;15(6):403-13 - PubMed
  23. Circulation. 2002 Jul 9;106(2):184-90 - PubMed
  24. Vaccine. 2007 Mar 8;25(12):2252-60 - PubMed
  25. Rev Med Interne. 1998 Apr;19(4):255-61 - PubMed
  26. Eur Heart J. 1999 Jan;20(2):121-7 - PubMed
  27. Int J Cardiol. 2006 Jul 28;111(1):98-103 - PubMed
  28. Circulation. 1999 Mar 30;99(12):1540-7 - PubMed
  29. Expert Rev Neurother. 2006 Feb;6(2):175-83 - PubMed
  30. Arch Intern Med. 2000 Jul 10;160(13):2027-32 - PubMed
  31. Stroke. 2006 Jul;37(7):1644; author reply 1645 - PubMed
  32. Circulation. 1999 Sep 28;100(13):1369-73 - PubMed
  33. Circulation. 1997 Oct 7;96(7):2144-8 - PubMed
  34. Am J Otolaryngol. 1990 Sep-Oct;11(5):313-7 - PubMed
  35. Clin Microbiol Infect. 1998 Jan;4 Suppl 4:S33-S36 - PubMed
  36. J Infect Dis. 2000 Jun;181 Suppl 3:S483-9 - PubMed
  37. Lancet. 1993 Jan 30;341(8840):255-9 - PubMed
  38. Mol Microbiol. 2006 Jan;59(1):152-67 - PubMed
  39. Am J Cardiol. 2000 Jan 15;85(2):140-6 - PubMed
  40. Helicobacter. 2005 Dec;10(6):623-9 - PubMed
  41. Mod Pathol. 2000 Feb;13(2):173-9 - PubMed
  42. Int Rev Immunol. 2002 Jan-Feb;21(1):27-31 - PubMed
  43. Atherosclerosis. 2006 Aug;187(2):439-40 - PubMed
  44. Stroke. 1998 Apr;29(4):773-8 - PubMed
  45. J Nutr. 2001 Oct;131(10):2798S-2804S - PubMed
  46. Circulation. 2001 Jun 19;103(24):2915-21 - PubMed
  47. J Investig Med. 1997 Apr;45(4):168-74 - PubMed
  48. Stroke. 2006 Feb;37(2):482-6 - PubMed
  49. Stroke. 1998 Feb;29(2):404-10 - PubMed
  50. Antimicrob Agents Chemother. 2002 Aug;46(8):2321-6 - PubMed
  51. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1075-80 - PubMed
  52. Circulation. 2003 Aug 12;108(6):678-83 - PubMed
  53. J Infect. 1997 Sep;35(2):171-6 - PubMed
  54. Endocr J. 2001 Apr;48(2):269-74 - PubMed
  55. J Infect Dis. 2002 Jun 1;185(11):1631-6 - PubMed
  56. J Clin Virol. 2000 Feb;16(1):17-24 - PubMed
  57. Transplantation. 2004 Feb 27;77(4):597-9 - PubMed
  58. Int J Circumpolar Health. 1998;57 Suppl 1:329-32 - PubMed
  59. J Pathol. 2000 Feb;190(3):237-43 - PubMed
  60. Circulation. 1993 Apr;87(4):1130-4 - PubMed
  61. J Immunol. 2000 Jan 1;164(1):13-7 - PubMed
  62. Stroke. 2007 Jan;38(1):12; author reply 13 - PubMed
  63. Atherosclerosis. 2003 Oct;170(2):223-8 - PubMed
  64. BMJ. 1995 Sep 16;311(7007):711-4 - PubMed
  65. Clin Exp Med. 2003 Nov;3(3):157-60 - PubMed
  66. Atherosclerosis. 2007 Jun;192(2):370-5 - PubMed
  67. J Clin Invest. 1997 Sep 1;100(5):996-1005 - PubMed
  68. Oral Dis. 2000 Nov;6(6):335-50 - PubMed
  69. Am J Med. 1993 Nov;95(5):499-504 - PubMed
  70. Trends Immunol. 2005 Jan;26(1):19-24 - PubMed
  71. Lancet. 1995 Jul 29;346(8970):310 - PubMed

Publication Types